Showing 1 - 16 results of 16 for search 'Ralph M. Wirtz', query time: 0.07s
Refine Results
-
1
Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies by Max Czajkowski, Daniel Kaemmerer, Jörg Sänger, Guido Sauter, Ralph M. Wirtz, Stefan Schulz, Amelie Lupp
Published 2022-07-01
Article -
2
Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non–muscle-invasive Bladder Cancer: A Case Report by Sarah Weiß, Steffen Hallmann, Stefan Koch, Sebastian Eidt, Robert Stoehr, Elke Veltrup, Jenny Roggisch, Ralph M. Wirtz, Thorsten H. Ecke
Published 2021-05-01
Article -
3
Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer. by Elena Fountzilas, Vassiliki Kotoula, Nikolaos Angouridakis, Ilias Karasmanis, Ralph M Wirtz, Anastasia G Eleftheraki, Elke Veltrup, Konstantinos Markou, Angelos Nikolaou, Dimitrios Pectasides, George Fountzilas
Published 2013-01-01
Article -
4
High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer by Danijel Sikic, Johannes Breyer, Arndt Hartmann, Maximilian Burger, Philipp Erben, Stefan Denzinger, Markus Eckstein, Robert Stöhr, Sven Wach, Bernd Wullich, Bastian Keck, Ralph M. Wirtz, Wolfgang Otto
Published 2017-06-01
Article -
5
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts by Danijel Sikic, Ralph M. Wirtz, Sven Wach, Lars Dyrskjøt, Philipp Erben, Christian Bolenz, Johannes Breyer, Wolfgang Otto, Katherine A. Hoadley, Seth P. Lerner, Markus Eckstein, Arndt Hartmann, Bastian Keck
Published 2019-04-01
Article -
6
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer by Danijel Sikic, Helge Taubert, Ralph M. Wirtz, Johannes Breyer, Markus Eckstein, Veronika Weyerer, Jennifer Kubon, Philipp Erben, Christian Bolenz, Maximilian Burger, Arndt Hartmann, Bernd Wullich, Sven Wach, Bastian Keck
Published 2021-06-01
Article -
7
The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases by Stacey A. Cohen, Ming Yu, Kelsey Baker, Mary Redman, Chen Wu, Tai J. Heinzerling, Ralph M. Wirtz, Elpida Charalambous, George Pentheroudakis, Vassiliki Kotoula, Konstantine T. Kalogeras, George Fountzilas, William M. Grady
Published 2017-05-01
Article -
8
Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study by Francesco Schettini, Silvana Saracchini, Anna Bassini, Wally Marus, Serena Corsetti, Ilaria Specogna, Manuela Bertola, Elvia Micheli, Ralph M. Wirtz, Mark Laible, Uğur Şahin, Carla Strina, Manuela Milani, Sergio Aguggini, Richard Tancredi, Elena Fiorio, Sandro Sulfaro, Daniele Generali
Published 2024-08-01
Article -
9
Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population by Marcus Schmidt, Veronika Weyer-Elberich, Jan G. Hengstler, Anne-Sophie Heimes, Katrin Almstedt, Aslihan Gerhold-Ay, Antje Lebrecht, Marco J. Battista, Annette Hasenburg, Ugur Sahin, Konstantine T. Kalogeras, Pirkko-Liisa Kellokumpu-Lehtinen, George Fountzilas, Ralph M. Wirtz, Heikki Joensuu
Published 2018-02-01
Article -
10
Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy by Eleni Timotheadou, Konstantine T. Kalogeras, Georgia-Angeliki Koliou, Ralph M. Wirtz, Flora Zagouri, Angelos Koutras, Elke Veltrup, Christos Christodoulou, George Pentheroudakis, Aris Tsiftsoglou, Pavlos Papakostas, Gerasimos Aravantinos, Vasilios Venizelos, Dimitrios Pectasides, Paris Kosmidis, Charisios Karanikiotis, Christos Markopoulos, Helen Gogas, George Fountzilas
Published 2017-08-01
Article -
11
Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study i... by George Pentheroudakis, Georgia Raptou, Vassiliki Kotoula, Ralph M Wirtz, Eleni Vrettou, Vasilios Karavasilis, Georgia Gourgioti, Chryssa Gakou, Konstantinos N Syrigos, Evangelos Bournakis, Grigorios Rallis, Ioannis Varthalitis, Eleni Galani, Georgios Lazaridis, George Papaxoinis, Dimitrios Pectasides, Gerasimos Aravantinos, Thomas Makatsoris, Konstantine T Kalogeras, George Fountzilas
Published 2015-01-01
Article -
12
PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma by Niklas Klümper, Lennert Wüst, Jonas Saal, Damian J. Ralser, Romina Zarbl, Jonas Jarczyk, Johannes Breyer, Danijel Sikic, Bernd Wullich, Christian Bolenz, Florian Roghmann, Michael Hölzel, Manuel Ritter, Sebastian Strieth, Arndt Hartmann, Philipp Erben, Ralph M. Wirtz, Jennifer Landsberg, Dimo Dietrich, Markus Eckstein
Published 2023-12-01
Article -
13
Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study. by Flora Stavridi, Konstantine T Kalogeras, Kyriaki Pliarchopoulou, Ralph M Wirtz, Zoi Alexopoulou, Flora Zagouri, Elke Veltrup, Eleni Timotheadou, Helen Gogas, Angelos Koutras, Georgios Lazaridis, Christos Christodoulou, George Pentheroudakis, Apostolos Laskarakis, Petroula Arapantoni-Dadioti, Anna Batistatou, Maria Sotiropoulou, Gerasimos Aravantinos, Pavlos Papakostas, Paris Kosmidis, Dimitrios Pectasides, George Fountzilas
Published 2016-01-01
Article -
14
CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell re... by Dimo Dietrich, Lutz Trojan, Niklas Klümper, Damian J Ralser, Romina Zarbl, Glen Kristiansen, Marieta Toma, Manuel Ritter, Michael Hölzel, Jörg Ellinger, Markus Eckstein, Danijel Sikic, Katrin Schlack, Andres Jan Schrader, Marc Rehlinghaus, Michèle J Hoffmann, Günter Niegisch, Annemarie Uhlig, Julie Steinestel, Konrad Steinestel, Ralph M Wirtz, Sebastian Strieth
Published 2021-08-01
Article -
15
Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperat... by George Pentheroudakis, Vassiliki Kotoula, Anastasia G Eleftheraki, Eleftheria Tsolaki, Ralph M Wirtz, Konstantine T Kalogeras, Anna Batistatou, Mattheos Bobos, Meletios A Dimopoulos, Eleni Timotheadou, Helen Gogas, Christos Christodoulou, Kyriaki Papadopoulou, Ioannis Efstratiou, Chrisoula D Scopa, Irene Papaspyrou, Dimitrios Vlachodimitropoulos, Helena Linardou, Epaminontas Samantas, Dimitrios Pectasides, Nicholas Pavlidis, George Fountzilas
Published 2013-01-01
Article -
16
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) by Johannes Breyer, Markus Eckstein, Danijel Sikic, Felix Wezel, Florian Roghmann, Mirco Brehmer, Ralph M. Wirtz, Jonas Jarczyk, Philipp Erben, Veronika Bahlinger, Franziska Goldschmidt, Guido Fechner, Jack Chen, Ellen Paxinos, Michael Bates, Maximilian Haas, Friedemann Zengerling, Christian Bolenz, Maximilian Burger, Arndt Hartmann, Maximilian C. Kriegmair, BRIDGE Consortium e.V.
Published 2023-09-01
Article